Gülşen Akman‐Demir

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease

Elaine F. Remmers, Fulya Coşan, Yohei Kirino et al. · Nature Genetics · 2010 · 676 citations · Full text

Life Sciences, Genetics, Immunology +16

Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis

Sven Jarius, Jette Frederikson, Patrick Waters et al. · Journal of the Neurological Sciences · 2010 · 169 citations

Medicine, Neurology, Ophthalmology +12

Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders

Sven Jarius, Christian Jacobi, de Sèze et al. · Multiple Sclerosis Journal · 2011 · 166 citations

Life Sciences, Immunology, Neurology +17

Interleukin-6 in neuro-Behçet’s disease: Association with disease subsets and long-term outcome

Gülşen Akman‐Demir, Erdem Tüzün, Sema İçöz et al. · Cytokine · 2008 · 129 citations

Life Sciences, Immunology, Neurology +16